公司資料
ASLAN Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- ASLN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Singapore and listed in the U
股價為何變動
Current closing-price context is not available for ASLN.
公司概覽
業務概覽
ASLAN Pharmaceuticals is a specialty biopharmaceutical company focused on dermatology and immunology. Its story centers on developing and commercializing therapies for inflammatory skin disease.
所在地與產業分類
ASLAN is headquartered in Singapore and listed in the U.S. market. It sits in specialty dermatology biopharma.
商業模式特徵
The company depends on clinical and commercial execution, plus capital discipline across a narrow portfolio. Investors watch product adoption, development milestones, and strategic changes.
生技產業定位
ASLAN occupies a niche dermatology-immunology position within biotech. It is a focused specialty story where launch and data execution are central to the stock.
未來催化劑
- ASLAN’s catalysts are varlitinib / oncology programs and any strategic step that clarifies the company’s future after the pipeline reset. The market is watching for a cleaner path forward.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。